Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855705) titled 'A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vaccine' on Sept. 28.

Study Type: Observational

Primary Sponsor: Sinovac Biotech Co., Ltd

Condition: Hepatitis A

Intervention: Biological: Inactivated HAV vaccine

Recruitment Status: Not recruiting

Date of First Enrollment: January 13, 2026

Target Sample Size: 105

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07855705

Published by HT Digital Content Services with permission from Health Daily Digest....